Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAS41004 (Bexarotene + Betamethasone) in Plaque Psoriasis
NCT01462643Phase 2Completed
- Sponsor
- Almirall
- Start
- Aug 2011
- Primary completion
- Sep 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bexarotene in plaque psoriasis, sponsored by Almirall. Started Aug 2011; status: completed.
02
Drugs
bexarotene
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01462643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01462643.